dystrophin expressing chimeric allogeneic/allogeneic myoblasts (Dystrogen Therapeutics)

N/A

Report date: 2025/03/18 18:24:36

Base Information

Drug Namedystrophin expressing chimeric allogeneic/allogeneic myoblasts (Dystrogen Therapeutics)
Drug Alias Namedystrophin expressing chimeric allogeneic/allogeneic myoblasts (University of Illinois)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionDystrophin expression stimulants
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesDystrogen Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A